# Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia

> **NCT01077375** · PHASE4 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 107 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Placebo
- **DRUG:** Milnacipran

## Key facts

- **NCT ID:** NCT01077375
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-12
- **Final completion:** 2011-01
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2012-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01077375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01077375, "Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01077375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*